Magali Matsumiya

发表

Gene Expression and Cytokine Profile Correlate With Mycobacterial Growth in a Human BCG Challenge Model

H. McShane, Joel Meyer, H. Fletcher, 2014, The Journal of infectious diseases.

Cytomegalovirus infection is a risk factor for TB disease in Infants

M. Tameris, M. Hatherill, B. Landry, 2017, bioRxiv.

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response

M. Hatherill, T. Scriba, W. Hanekom, 2014, BMC Infectious Diseases.

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection

N. Beeching, T. Fletcher, A. Cunningham, 2018, Front. Immunol..

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays

P. Bettencourt, H. McShane, M. O’Shea, 2017, Scientific Reports.

Roles for Treg Expansion and HMGB1 Signaling through the TLR1-2-6 Axis in Determining the Magnitude of the Antigen-Specific Immune Response to MVA85A

H. McShane, Joel Meyer, H. Fletcher, 2013, PloS one.

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin

P. Bettencourt, D. Greaves, A. Hale, 2018, Nature Communications.

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants

M. Tameris, M. Hatherill, B. Landry, 2019, JCI insight.

Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine , MVA 85 A

M. Tameris, T. Scriba, W. Hanekom, 2017 .

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A

M. Tameris, T. Scriba, W. Hanekom, 2014, Clinical and Vaccine Immunology.

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults

H. McShane, A. Lawrie, A. Hill, 2012, Human vaccines & immunotherapeutics.

T-cell activation is an immune correlate of risk in BCG vaccinated infants

M. Tameris, M. Hatherill, B. Landry, 2016, Nature Communications.

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).

H. McShane, P. Marsh, H. Fletcher, 2013, Tuberculosis.

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection

H. McShane, M. O’Shea, Joel Meyer, 2020, Frontiers in Immunology.

Cytomegalovirus infection is a risk factor for TB disease in 1 Infants 2

M. Tameris, M. Hatherill, B. Landry, 2019 .